COGT’s 18.08% Gain This Week Has Revealed Something We Didn’t Know Before

During the last session, Cogent Biosciences Inc (NASDAQ:COGT)’s traded shares were 1.02 million, with the beta value of the company hitting 1.58. At the end of the trading day, the stock’s price was $6.89, reflecting an intraday gain of 2.07% or $0.14. The 52-week high for the COGT share is $13.50, that puts it down -95.94 from that peak though still a striking 46.73% gain since the share price plummeted to a 52-week low of $3.67. The company’s market capitalization is $715.94M, and the average intraday trading volume over the past 10 days was 1.37 million shares, and the average trade volume was 2.24 million shares over the past three months.

Cogent Biosciences Inc (NASDAQ:COGT) trade information

Cogent Biosciences Inc (COGT) registered a 2.07% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 2.07% in intraday trading to $6.89, hitting a weekly high. The stock’s 5-day price performance is 18.08%, and it has moved by -2.27% in 30 days. Based on these gigs, the overall price performance for the year is -36.14%. The short interest in Cogent Biosciences Inc (NASDAQ:COGT) is 9.63 million shares and it means that shorts have 3.16 day(s) to cover.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Cogent Biosciences Inc (COGT) estimates and forecasts

Statistics show that Cogent Biosciences Inc has outperformed its competitors in share price, compared to the industry in which it operates. Cogent Biosciences Inc (COGT) shares have gone down -27.85% during the last six months, with a year-to-date growth rate more than the industry average at 21.90% against 13.60. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 5.60% this quarter and then jump 16.90% in the quarter after that.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 15.33%. While earnings are projected to return 18.60% in 2024.

COGT Dividends

Cogent Biosciences Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Cogent Biosciences Inc (NASDAQ:COGT)’s Major holders

Cogent Biosciences Inc insiders own 0.14% of total outstanding shares while institutional holders control 99.98%, with the float percentage being 100.12%. RA Capital Management, L.P. is the largest shareholder of the company, while 203 institutions own stock in it. As of Jun 29, 2023, the company held over 6.42 million shares (or 7.51% of all shares), a total value of $75.97 million in shares.

The next largest institutional holding, with 5.63 million shares, is of Tcg Crossover Management, Llc’s that is approximately 6.59% of outstanding shares. At the market price on Jun 29, 2023, these shares were valued at $66.67 million.

Also, the Mutual Funds coming in first place with the largest holdings of Cogent Biosciences Inc (COGT) shares are Mutual Fund Ser Tr-Eventide Healthcare & Life Sciences Fund and Vanguard Total Stock Market Index Fund. Data provided on Jun 29, 2023 indicates that Mutual Fund Ser Tr-Eventide Healthcare & Life Sciences Fund owns about 3.44 million shares. This amounts to just over 4.03 percent of the company’s overall shares, with a $40.74 million market value. The same data shows that the other fund manager holds slightly less at 2.47 million, or about 2.89% of the stock, which is worth about $29.25 million.